Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.

[1]  P. Mclaughlin,et al.  Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  B. Cheson,et al.  Mantle cell lymphoma: clinicopathologic features and treatments. , 2003, Oncology.

[3]  N. Schmitz,et al.  An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation , 2003, Bone Marrow Transplantation.

[4]  Alan M. Miller,et al.  A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. , 2003, Blood.

[5]  D. Weisenburger,et al.  Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries , 2003, British journal of haematology.

[6]  N. Schmitz,et al.  Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. , 2002, Blood.

[7]  R. Bouabdallah,et al.  Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study , 2002, Leukemia.

[8]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[9]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[10]  I. Flinn,et al.  Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Sweetenham.  Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials? , 2001, Bone Marrow Transplantation.

[12]  I. Flinn,et al.  Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  W. Chan,et al.  Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  B. Quesnel,et al.  Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study , 2000, Bone Marrow Transplantation.

[15]  N. Schmitz,et al.  The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients. , 2000, The hematology journal : the official journal of the European Haematology Association.

[16]  H. Kantarjian,et al.  Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  A. López-Guillermo,et al.  Mantle cell lymphoma , 1998, Seminars in hematology.

[18]  P. Moreau,et al.  High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience , 1998, Bone Marrow Transplantation.

[19]  J. Gribben,et al.  High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Salles,et al.  Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  F. Cavalli,et al.  Patterns of survival in mantle cell lymphoma. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  V. Diehl,et al.  Immunophenotyping of low‐grade B‐cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification , 1993, British journal of haematology.

[23]  S. Piantadosi,et al.  Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. , 1991, Blood.

[24]  J. Wagner,et al.  Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. , 1990, Blood.

[25]  O. Colvin,et al.  Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. , 1986, The New England journal of medicine.

[26]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[27]  D. Cox.  Regression Models and Life-Tables , 1972 .

[28]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[29]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .